Analyst says acquisition strengthens Coloplast's core competencies
The acquisition of the Swedish company Atos Medical could lay the foundation for further top line growth and increased revenue for Coloplast, a Sydbank analyst assesses.
BY MARKETWIRE, TRANSLATED BY DANIEL PEDERSEN
Coloplast's acquisition of Atos Medical could prove to be a solid growth driver within the Danish medtech company's chronic care business, says Senior Analyst at Sydbank Søren Løntoft Hansen.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Coloplast acquires Atos Medical for USD 2.5bn
For subscribers
